---

$25.06

+0.4100 ( +1.66% ) 1.2M

JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company's goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations.

Open	$25.06
Previous Close	$24.65
Volume	1.2M
Market Cap	$4.62B
Day Range	$24.10 - $25.13
52 Week Range	$22.76 - $28.52
Shares Outstanding	187.22M
Change %	+1.66%
Net Change	▲ 0.4100
Insider Ownership	0.00%
Exchange	NYSE
Sector	Utilities
Industry	Environmental Services
IPO Year	2026
Country	United States
Underwriter	BofA Securities, J.P. Morgan, Wells Fargo Securities, Barclays, Goldman Sachs, RBC Capital Markets, Morgan Stanley, BNP Paribas, Credit Agricole CIB, KeyBanc Capital Markets, PNC Capital Markets, Scotia Capital, TD Securities, Truist Securities, BTIG, Cap

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-10-09	Buy	10000.00	DANZIGER DAVID C.
2024-12-10	Buy	3000.00	Johnson Virland A
2024-09-11	Buy	5000.00	Tassiopoulos Peter